Literature DB >> 23796748

Novel roles for complement receptors in T cell regulation and beyond.

Claudia Kemper1, Jörg Köhl.   

Abstract

Complement receptors are expressed on cells of the innate and the adaptive immune system. They play important roles in pathogen and danger sensing as they translate the information gathered by complement fluid phase sensors into cellular responses. Further, they control complement activation on viable and apoptotic host cells, clearance of immune complexes and mediate opsonophagocytosis. More recently, evidence has accumulated that complement receptors form a complex network with other innate receptors systems such as the Toll-like receptors, the Notch signaling system, IgG Fc receptors and C-type lectin receptors contributing to the benefit and burden of innate and adaptive immune responses in autoimmune and allergic diseases as well as in cancer and transplantation. Here, we will discuss recent developments and emerging concepts of complement receptor activation and regulation with a particular focus on the differentiation, maintenance and contraction of effector and regulatory T cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23796748     DOI: 10.1016/j.molimm.2013.05.223

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  28 in total

Review 1.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

2.  Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Authors:  Zhangsheng Yang; Turner Conrad; Zhou Zhou; Jianlin Chen; Pavel Dutow; Andreas Klos; Guangming Zhong
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

3.  Emerging role of C5a/C5aR IL-17A axis in cGVHD.

Authors:  Xiaomei Chen; Peilong Lai; Yulian Wang; Chang He; Suijing Wu; Xin Huang; Suxia Geng; Chengwei Luo; Wei Ling; Lingji Zeng; Peng Li; Zhiwu Jiang; Jianyu Weng; Xin Du
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 4.  Novel mechanisms and functions of complement.

Authors:  George Hajishengallis; Edimara S Reis; Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Immunol       Date:  2017-11-16       Impact factor: 25.606

5.  Structural basis for therapeutic inhibition of complement C5.

Authors:  Matthijs M Jore; Steven Johnson; Devon Sheppard; Natalie M Barber; Yang I Li; Miles A Nunn; Hans Elmlund; Susan M Lea
Journal:  Nat Struct Mol Biol       Date:  2016-03-28       Impact factor: 15.369

6.  Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation.

Authors:  Elizabeth V Clarke; Brian M Weist; Craig M Walsh; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-11-07       Impact factor: 4.962

Review 7.  Complement and the Regulation of T Cell Responses.

Authors:  Erin E West; Martin Kolev; Claudia Kemper
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

Review 8.  More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.

Authors:  George Hajishengallis; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 9.  Complement modulation of T cell immune responses during homeostasis and disease.

Authors:  Elizabeth V Clarke; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

Review 10.  Applying complement therapeutics to rare diseases.

Authors:  Edimara S Reis; Dimitrios C Mastellos; Despina Yancopoulou; Antonio M Risitano; Daniel Ricklin; John D Lambris
Journal:  Clin Immunol       Date:  2015-09-01       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.